AI, Technology & Health: What's Smell Got to Do With It?
summary
Breath contains 2,000–3,000 volatile organic compounds and only 11 VOCs diagnose liver cirrhosis, 13 signal lung cancer and 3 indicate diabetes; the approach uses genetically modified olfactory cells on a microfluidic chip to transduce VOCs into electrical signals. Prototype fits half a smartphone, currently producing 50 devices produced now, aims for 10,000/month next year, and targets a <$60 production cost per base unit with monthly consumables. Addressable markets cited: diagnostics >$390B and broader applications ≈$250B.
AI-written summary · about
chapters (4)
related talks
45mTeaching Machines How to Smell Disease — Lessons Learned
40mSniffing the Metaverse
30mAIMED: AI for Prostate Cancer Detection and Immunotherapy Response
01h 01mVocal biomarkers for disease detection
29mAI & Neurobiology of Deception: How AI Helps Us Understand Ourselves
11mAir Designed for You: Perspectives on Interior Air Quality & AI
07mHow AI is Enabling Healthcare's Biggest Blindspot
13mWhen AI Gets a White Coat